Physician profile
Jorge Ramirez
NPI 1003127002
$12,827.43
in general payments reported to CMS, 2019-2025
17 companies · $30.00 in 2025
The $30.00 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,234 · 2020: $215 · 2021: $3,343 · 2022: $461 · 2023: $7,410 · 2024: $135 · 2025: $30.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,404 · Travel and Lodging: $793 · Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,404.38 |
| Travel and Lodging | $792.84 |
| Food and Beverage | $377.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,536.01 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Abiomed | $1,773.02 | 2021 | |
| Axonics, INC. | $1,452.41 | 2021 | |
| Neotract INC. | $1,230.88 | 2019-2020 | |
| Astellas Pharma US INC | $219.95 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $125.15 | 2023-2024 | Gemtesa |
| Urovant Sciences INC | $119.00 | 2021-2022 | |
| Janssen Biotech, INC. | $105.10 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $63.23 | 2022-2023 | Lynparza, Keytruda |
| Myriad Genetic Laboratories, INC. | $59.28 | 2024-2025 | Prolaris |
| Teleflex LLC | $39.12 | 2024 | Urolift |
| Urogen Pharma, INC. | $25.09 | 2021 | |
| 180 Medical, INC. | $19.36 | 2023 | Cure Catheter |
| Abbvie INC. | $17.01 | 2019 | |
| Endo Pharmaceuticals INC. | $15.37 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $14.81 | 2019 | |
| Edap Technomed INC | $12.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.